dsRNA receptors contribute to cytokine expression in poly(I:C)-stimulated, IFN-γ-primed VSMC. (A) VSMCs were transfected with either control non-silencing (NS) siRNA or 3 different siRNA sequences to TLR3, MDA5, and RIG-I for 24 hr and then treated with IFN-γ at 10 ng/mL for 72 hr. RNA was extracted and TLR3, MDA5, and RIG-I transcript levels were determined by real-time RT-PCR and normalized to GAPDH mRNA. (B) Additionally, lysates were extracted from siRNA-transfected, IFN-γ-primed VSMCs and immunobloted for TLR3, MDA5, RIG-I, and β-actin. (C) IFN-γ-primed VSMCs were transfected with either NS-siRNA, TLR3 siRNA, or MDA5 siRNA for 24 hr and then treated with poly(I:C) at 1 μg/mL for 6 hr. RNA was extracted and TNF-α, IP-10, and IFN-β transcript levels were measured. (D) Alternatively, siRNA-transfected, IFN-γ-primed VSMCs were treated with self-RNA at 1 μg/mL complexed with lipofectamine for 6 hr, and TNF-α, IP-10, and IFN-β transcript levels were measured. Data are means ± SE (n = 3) and are representative of 5 experiments with poly(I:C) and 2 experiments with self-RNA. *P < 0.05 and **P < 0.01 siRNA vs. NS-siRNA. Additionally, the siRNA effects were confirmed by ELISA analysis of secreted TNF-α and IP-10 from IFN-γ-primed VSMC treated with poly(I:C) for 48 hr (E) and of secreted IP-10 in response to self-RNA complexed to lipofectamine for 48 hr (F). Data are means ± SE (n = 12 from 2 donors). *P < 0.05 and **P < 0.01 siRNA vs. NS-siRNA.